Logo.jpg
PROPHASE LABS TO PRESENT 2023 YEAR END FINANCIAL RESULTS ON MARCH 15, 2024
March 08, 2024 08:00 ET | ProPhase Labs, Inc.
GARDEN CITY, NY, March 08, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), announced today that they will be presenting full year 2023 financial results on a virtual conference call...
Mammography Market Worth US$ 6.9 Billion by 2033, By Persistence Market Research
January 14, 2024 14:15 ET | Persistence Market Research
New York, Jan. 15, 2024 (GLOBE NEWSWIRE) -- Mammography Market: A Snapshot and Growth Projections Mammography is a diagnostic imaging technique specifically designed for breast examination, playing...
84bd90f5-4a1f-42a8-8eb1-5cb062a0b6ac.png
Molecular Diagnostic Market Growth: Projections Suggest a 10.6% CAGR, with Anticipated to USD 51 Billion by 2032
January 11, 2024 08:12 ET | Market.Us
New York, Jan. 11, 2024 (GLOBE NEWSWIRE) -- According to the market.us, the Molecular Diagnostic Market Size is anticipated to reach approximately USD 51 Billion by 2032, experiencing growth from...
Future Market Insights.png
Global Market for Hepatitis B Diagnostic Tests to Expand at a 6.5% CAGR through 2033, reaching US$ 1,744.26 Million | Future Market Insights Inc.
October 10, 2023 05:30 ET | Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Oct. 10, 2023 (GLOBE NEWSWIRE) -- The global hepatitis B diagnostic tests market is anticipated to reach a valuation of US$ 872.5 million in 2023, driven by health screenings and...
Polarean logo.png
Appointment of Dr. Christopher von Jako as new CEO
June 21, 2023 09:00 ET | Polarean Imaging plc
Durham, N.C., June 21, 2023 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX), the medical imaging company, announces that the Company’s Board of Directors has appointed Christopher von Jako,...
Polarean logo.png
First clinical scan using XENOVIEW conducted at Cincinnati Children’s Hospital Medical Center
May 11, 2023 10:05 ET | Polarean Imaging plc
Durham, N.C. , May 11, 2023 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM:POLX), the medical imaging company, announces that the first clinical scan utilising its XENOVIEW (xenon Xe 129...
Polarean logo.png
Polarean to be a featured company at 2023 ATS Respiratory Innovation Summit
May 03, 2023 12:34 ET | Polarean Imaging plc
Durham, N.C., May 03, 2023 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX), the medical imaging technology company, has been selected as one of the featured companies as a poster presenter at...
Polarean.jpg
FDA Approves Polarean’s XENOVIEW™ (xenon Xe 129 hyperpolarized) for use with MRI for the Evaluation of Lung Ventilation
December 28, 2022 08:00 ET | Polarean Imaging plc
Durham, N.C., Dec. 28, 2022 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX), the medical imaging technology company, announces that the U.S. Food and Drug Administration (“FDA”) has granted...